SLC16A11
Monocarboxylate transporter 11
Also known as: MOT11_HUMAN
Protein identityUniProt · HPA
- UniProt accession
- Q8NCK7
- Gene
- SLC16A11
- Canonical length
- 471 aa
- Protein class
- Predicted membrane proteins
OverviewNCBI Gene
No narrative summary is available for SLC16A11 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
471 residues, UniProt reviewed canonical sequence.
>Q8NCK7|SLC16A11
1 MPAPQRKHRR GGFSHRCFPT PQTAMTPQPA GPPDGGWGWV VAAAAFAING LSYGLLRSLG
61 LAFPDLAEHF DRSAQDTAWI SALALAVQQA ASPVGSALST RWGARPVVMV GGVLASLGFV
121 FSAFASDLLH LYLGLGLLAG FGWALVFAPA LGTLSRYFSR RRVLAVGLAL TGNGASSLLL
181 APALQLLLDT FGWRGALLLL GAITLHLTPC GALLLPLVLP GDPPAPPRSP LAALGLSLFT
241 RRAFSIFALG TALVGGGYFV PYVHLAPHAL DRGLGGYGAA LVVAVAAMGD AGARLVCGWL
301 ADQGWVPLPR LLAVFGALTG LGLWVVGLVP VVGGEESWGG PLLAAAVAYG LSAGSYAPLV
361 FGVLPGLVGV GGVVQATGLV MMLMSLGGLL GPPLSGFLRD ETGDFTASFL LSGSLILSGS
421 FIYIGLPRAL PSCGPASPPA TPPPETGELL PAPQAVLLSP GGPGSTLDTT CLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC16A11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 11
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 12 nTPM
- thyroid gland: 9.8 nTPM
- liver: 7.5 nTPM
- salivary gland: 7.1 nTPM
- fallopian tube: 5.5 nTPM
- parathyroid gland: 5.1 nTPM
Single-cell type
- fallopian tube ciliated cells: 92 nCPM
- epididymal clear cells: 53 nCPM
- müller glia: 28 nCPM
- tuft cells: 23 nCPM
- epididymal efferent duct absorptive cells: 22 nCPM
- epididymal principal cells: 22 nCPM
Immune cell
- gdT-cell: 1.5 nTPM
- memory CD8 T-cell: 1.4 nTPM
- naive CD8 T-cell: 1.3 nTPM
- naive B-cell: 1 nTPM
- MAIT T-cell: 0.9 nTPM
- naive CD4 T-cell: 0.7 nTPM
Brain region
- choroid plexus: 15 nTPM
- cerebellum: 4.9 nTPM
- spinal cord: 4.6 nTPM
- medulla oblongata: 4.5 nTPM
- hypothalamus: 4.4 nTPM
- midbrain: 3.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about SLC16A11.
Disease | AllUniProt
Conditions SLC16A11 is implicated in, by any mechanism.
- Type 2 diabetes mellitus (T2D) MIM:125853
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.44
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.38
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- monocarboxylic acid transmembrane transporter activity
- pyruvate transmembrane transporter activity
- symporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of SLC16A11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC16A11 as an antibody target. Whether an autoantibody or antibody against SLC16A11 could matter depends on whether native SLC16A11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC16A11 is annotated at the cell surface, where native SLC16A11 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC16A11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...